Medicine and Dentistry
Posttransplant Lymphoproliferative Disease
62%
Dexamethasone
50%
Plasmacytoma
50%
Pediatrics
50%
Transplantation
25%
Patient
25%
Hematological Cancer
25%
Immunosuppressive Treatment
12%
Vincristine
12%
Drug Megadose
12%
Doxorubicin
12%
Lymphoma
12%
Malignant Neoplasm
12%
Thalidomide
12%
Myeloma
12%
Multiple Myeloma
12%
Liver Graft
12%
B-Cell Lymphoma
12%
T-Cell Lymphoma
12%
Intestine Graft
12%
Lymphoproliferative Disease
12%
Salicylate Sodium
12%
Bortezomib
12%
Liver
12%
Adult
12%
Cancer
12%
Blood
12%
Organ
12%
INIS
transplants
100%
pediatrics
50%
diseases
50%
dexamethasone
50%
cancer
37%
blood
37%
patients
25%
liver
25%
lymphomas
25%
adults
12%
organs
12%
populations
12%
immunosuppression
12%
malignancies
12%
doses
12%
adriamycin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Posttransplant Lymphoproliferative Disease
62%
Dexamethasone
50%
Plasmacytoma
50%
Doxorubicin
12%
Thalidomide
12%
Lymphoma
12%
B Cell Lymphoma
12%
Multiple Myeloma
12%
Malignant Neoplasm
12%
Vincristine
12%
Bortezomib
12%
Myeloma
12%
T Cell Lymphoma
12%
Lymphoproliferative Disease
12%
Salicylate Sodium
12%
Biochemistry, Genetics and Molecular Biology
Dexamethasone
50%
Pediatrics
50%
T Cell
12%
B Cell
12%
Drug Megadose
12%